| Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains S Zhu, D Regev, M Watanabe, D Hickman, N Moussatche, DM Jesus, ... PLoS pathogens 9 (9), e1003592, 2013 | 126 | 2013 |
| Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis EM Pereira, TB Machado, ICR Leal, DM Jesus, CRA Damaso, AV Pinto, ... Annals of Clinical Microbiology and Antimicrobials 5, 1-7, 2006 | 101 | 2006 |
| Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae) PP Afonso, PM Silva, LC Schnellrath, DM Jesus, J Hu, Y Yang, R Renne, ... Journal of virology 86 (9), 5039-5054, 2012 | 41 | 2012 |
| A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil CRA Damaso, SA Reis, DM Jesus, PSF Lima, N Moussatché Diagnostic microbiology and infectious disease 57 (1), 39-46, 2007 | 40 | 2007 |
| Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus DM Jesus, LT Costa, DL Gonçalves, CA Achete, M Attias, N Moussatché, ... Journal of virology 83 (22), 11477-11490, 2009 | 24 | 2009 |
| In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC DM Jesus, N Moussatché, CR Damaso International Journal of Antimicrobial Agents 33 (1), 75-79, 2009 | 15 | 2009 |
| Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4 DM Jesus, N Moussatche, BBD McFadden, CP Nielsen, SM D’Costa, ... Virology 481, 1-12, 2015 | 14 | 2015 |
| Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid DM Jesus, N Moussatche, RC Condit Journal of Virology 88 (24), 14017-14029, 2014 | 10 | 2014 |
| An improved high pressure freezing and freeze substitution method to preserve the labile vaccinia virus nucleocapsid DM Jesus, N Moussatche, RC Condit Journal of Structural Biology 195 (1), 41-48, 2016 | 5 | 2016 |
| Development of a 1-step cell-based assay for cost-effective screening of antiviral drugs for vaccinia virus DM Jesus, ÉS Santos, LC Schnellrath, CR Damaso Diagnostic microbiology and infectious disease 64 (3), 350-353, 2009 | 4 | 2009 |
| Development of a Robust Process and Analytics for scAAV9 Manufacture D Jesus, M Gosse, C Troche, M Breedlove, K Meyer, S D'Costa HUMAN GENE THERAPY 33 (23-24), A96-A96, 2022 | | 2022 |
| Development Of An Upstream Process And Analytics For AAV Manufacturing M Gosse, S Likhite, D Jesus, K Meyer, S D’Costa MOLECULAR THERAPY 30 (4), 539-539, 2022 | | 2022 |
